MediciNova (MNOV) Metrics: History & Chart

MediciNova, Inc.(MNOV)

Biotechnology · La Jolla, CA

$1.68-0.07 (-4.21%)

Delayed quote: Oct 6, 2026, 11:49 AM EDT

About MediciNova, Inc.

MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United States. Its robust development pipeline features MN-166 (ibudilast), an oral agent with both anti-inflammatory and neuroprotective properties, currently being investigated for a range of neurological conditions. These include primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and various forms of substance dependence and addiction. The company's portfolio also comprises MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist aimed at treating acute asthma attacks; MN-001 (tipelukast), an orally available small molecule designed for fibrotic disorders like nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent intended for solid tumor oncology. MediciNova has established strategic partnerships with companies such as Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Angiogene Pharmaceuticals Ltd., and Meiji Seika Kaisha Ltd. Established in 2000, the company's headquarters are situated in La Jolla, California.

La Jolla, CA

6 employees

www.medicinova.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Yuichi Iwaki

View full financials

Third-Party DCF Estimate (FMP)	$0.61
Price Gap vs Third-Party Estimate	-64.08%

7D Total Return	-16.19%
30D Total Return	+7.98%
YTD Total Return	+34.35%
1Y Total Return	+37.50%
3Y Total Return	-11.56%
5Y Total Return	-51.90%
10Y Total Return	-75.47%
15Y Total Return	-14.12%
20Y Total Return	N/A

2026	+34.35%
2025	-37.62%
2024	+40.00%
2023	-26.83%
2022	-23.51%
2021	-49.05%
2020

CAGR TTM	+37.29%
CAGR 3Y	-4.01%
CAGR 5Y	-13.62%
CAGR 10Y	-13.11%
CAGR 15Y	-1.01%
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

MNOV Valuation Metrics

MNOV Stock Price Metrics

MNOV Dividend Metrics

MNOV Growth Rate Metrics

MNOV Discounted Cash Flow Metrics

MNOV Returns By Period

MNOV Yearly Returns

MNOV Average Annual Returns By Period (CAGR)

MNOV Revenue Metrics

MNOV PE Ratio Metrics

MNOV PS Ratio Metrics

MNOV PB Ratio Metrics

MNOV Price to Free Cash Flow Ratio Metrics

MNOV Debt to Equity Ratio Metrics

MNOV PEG Ratio Metrics

MNOV FCF Yield

MNOV Earnings Yield

MNOV EBITDA Yield

MNOV OCF Yield

MNOV EV/EBIT Ratio Metrics

MNOV EV/EBITDA Ratio Metrics

MNOV EV/Assets Ratio Metrics

MNOV EV/Sales Ratio Metrics

MNOV Current Ratio Metrics

MNOV Quick Ratio Metrics

MNOV ROIC Metrics

MNOV Return on Assets Metrics

MNOV Return on Equity Metrics

MNOV Net Profit Margin Metrics

MNOV Gross Profit Margin Metrics

MNOV Tax Rate Metrics

PS Ratio	94.11
PS Ratio Avg TTM	211.96
PS Ratio Avg 3Y	162.01
Current VS TTM Avg	-55.60%
Current VS 3Y Avg	-41.91%
Current VS 5Y Avg	-31.25%

PB Ratio	2.32
PB Ratio Avg TTM	1.67
PB Ratio Avg 3Y	1.45
Current VS TTM Avg	+38.68%
Current VS 3Y Avg	+59.90%
Current VS 5Y Avg	+55.15%

PFCF Ratio	122.47
PFCF Ratio Avg TTM	111.16
PFCF Ratio Avg 3Y	111.16
Current VS TTM Avg	+10.18%
Current VS 3Y Avg	+10.18%
Current VS 5Y Avg	+10.18%

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	-30.40%
Current VS 3Y Avg	-48.56%
Current VS 5Y Avg	-55.56%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.82%
FCF Yield Avg TTM	0.90%
FCF Yield Avg 3Y	0.90%
Current VS TTM Avg	-8.89%
Current VS 3Y Avg	-8.89%
Current VS 5Y Avg	-8.89%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.52
Ev/Assets Ratio Avg TTM	0.88
Ev/Assets Ratio Avg 3Y	0.65
Current VS TTM Avg	+73.68%
Current VS 3Y Avg	+132.82%
Current VS 5Y Avg	+120.38%

Ev/Sales Ratio	66.63
Ev/Sales Ratio Avg TTM	117.30
Ev/Sales Ratio Avg 3Y	80.59
Current VS TTM Avg	-43.20%
Current VS 3Y Avg	-17.32%
Current VS 5Y Avg	-1.39%

Current Ratio	8.75
Current Ratio Avg TTM	9.83
Current Ratio Avg 3Y	14.47
Current VS TTM Avg	-10.92%
Current VS 3Y Avg	-39.51%
Current VS 5Y Avg	-45.77%

Quick Ratio	8.75
Quick Ratio Avg TTM	9.83
Quick Ratio Avg 3Y	14.47
Current VS TTM Avg	-10.92%
Current VS 3Y Avg	-39.51%
Current VS 5Y Avg	-45.77%

ROIC	(31.62%)
ROIC Avg 3Y	(23.94%)
ROIC Avg 5Y	(21.03%)
Current VS 3Y Avg	-32.08%
Current VS 5Y Avg	-50.38%
Current VS 10Y Avg	-46.06%

ROA	(26.59%)
ROA Avg TTM	(6.18%)
ROA Avg 3Y	(5.20%)
Current VS TTM Avg	-329.96%
Current VS 3Y Avg	-411.79%
Current VS 5Y Avg	-459.80%

ROE	(28.85%)
ROE Avg TTM	(27.99%)
ROE Avg 3Y	(21.38%)
Current VS TTM Avg	-3.06%
Current VS 3Y Avg	-34.97%
Current VS 5Y Avg	-48.85%

Net Profit Margin	(1168.20%)
Net Profit Margin Avg TTM	(1729.20%)
Net Profit Margin Avg 3Y	(670.64%)
Current VS TTM Avg	+32.44%
Current VS 3Y Avg	-74.19%
Current VS 5Y Avg	-3138.83%

Gross Profit Margin	7.58%
Gross Pft Margin Avg TTM	26.05%
Gross Pft Margin Avg 3Y	2.68%
Current VS TTM Avg	-70.90%
Current VS 3Y Avg	+182.47%
Current VS 5Y Avg	+380.19%

Tax Rate	0.05%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A